DAVID A. MCCARRON, M.D.
To the editor: The article by Kuhlmann and colleagues (1) and the accompanying editorial in the January 1980 (2) issue both point out the need for long-term follow-up data on patients with renovascular hypertension treated by percutaneous transluminal dilatation. Two aspects of the article concern me: First, why did the authors choose to report only subjects with unilateral disease involving the left side; second, a number of cases seem to be the same ones that the authors described at the 51st Scientific Session of the American Heart Association (3) in November 1978. If the abstract was submitted by the deadline
MCCARRON DA. Percutaneous Transluminal Dilatation for Renovascular Hypertension. Ann Intern Med. ;92:865–866. doi: 10.7326/0003-4819-92-6-865_2
Download citation file:
Published: Ann Intern Med. 1980;92(6):865-866.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use